We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
400 hedge funds and large institutions have $19B invested in Alnylam Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 139 increasing their positions, 132 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
25% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 44
23% more capital invested
Capital invested by funds: $15.4B → $19B (+$3.54B)
3% more funds holding
Funds holding: 390 → 400 (+10)
2% more ownership
Funds ownership: 93.54% → 95.54% (+2%)
6% more call options, than puts
Call options by funds: $269M | Put options by funds: $253M
5% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 132
Holders
400
Holders Change
+10
Holders Change %
+2.56%
% of All Funds
6.96%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.16%
New
55
Increased
139
Reduced
132
Closed
44
Calls
$269M
Puts
$253M
Net Calls
+$16.1M
Net Calls Change
-$13.4M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$160M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$146M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$139M |
| 4 |
Holocene Advisors
New York
|
+$81.3M |
| 5 |
JP Morgan Chase
New York
|
+$60.1M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
-$73.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46.9M |
| 3 |
BlackRock
New York
|
-$46.3M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$34.1M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$32.8M |
